Justice Department Has Major 'Systemic' Issues With Sexual Harassment
It's going to take "high level action" to fix the issues, according to a report from the department's inspector general.LEARN MORE
Several sexual harassment reports revealed nearly $200,000 of taxpayer money had been used to settle cases since 2003.
A bill introduced this week in the House of Representatives is aimed at changing how sexual misconduct complaints are handled, and it includes a requirement that lawmakers pay out settlements themselves.
A string of sexual harassment reports involving four House members revealed nearly $200,000 of taxpayer money had been used to settle complaints against lawmakers in the last 15 years. The new bill would end that practice. It would also prohibit lawmakers from using their office budgets to settle claims.
But according to Bloomberg, the bill would also cut an independent ethics watchdog out of the loop.
Currently, the Office of Congressional Ethics reviews allegations of congressional misconduct and can send cases to the House Ethics Committee for more attention. When that happens, the OCE almost always publishes a report. This new bill would create a new office to review complaints and refer them to the ethics committee.
Some outside Congress worry that particular measure would lead to a lack of transparency.
House Speaker Paul Ryan has praised the bill, and it's got support from Democrats as well. It's expected to pass easily.
If the vote to expel Santos is successful, he will become just the sixth person ever to be kicked out of the House of Representatives.
The White House and House Republicans have remained at odds over an agreement to house 2,000 migrants on federal land.
Santos could become just the third member of Congress in the last 160 years to be expelled.
The 19-year-old son of NBA star LeBron James collapsed on the basketball court during a USC team workout in July.
With a commitment to protecting and serving, meet some of the furry heroes who diligently work in airports across the nation.
CAR-T therapies are approved under several products: Abecma, Breyanzi, Carvykti, Kymriah, Tecartus and Yescarta.